Teladoc Health (TDOC) Projected to Announce Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is expected to post its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to post earnings of ($0.24) per share and revenue of $614.9840 million for the quarter. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Interested persons can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 5:00 PM ET.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The company had revenue of $613.85 million for the quarter, compared to the consensus estimate of $611.04 million. During the same quarter last year, the company earned ($0.53) earnings per share. The company’s revenue was down 2.5% compared to the same quarter last year. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Teladoc Health Trading Up 0.6%

NYSE TDOC opened at $9.71 on Wednesday. The company has a market capitalization of $1.75 billion, a price-to-earnings ratio of -10.01 and a beta of 2.10. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $9.89. The company’s fifty day moving average price is $7.92 and its two-hundred day moving average price is $6.48.

Insider Buying and Selling at Teladoc Health

In other news, CEO Charles Divita III sold 19,132 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $145,977.16. Following the transaction, the chief executive officer directly owned 389,894 shares in the company, valued at approximately $2,974,891.22. This trade represents a 4.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of Teladoc Health stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $47,275.48. Following the completion of the transaction, the insider directly owned 57,671 shares of the company’s stock, valued at $440,029.73. This trade represents a 9.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 39,195 shares of company stock worth $299,058 in the last ninety days. 0.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently bought and sold shares of TDOC. IFP Advisors Inc lifted its holdings in Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after acquiring an additional 3,210 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 2,810 shares during the period. Van ECK Associates Corp grew its holdings in shares of Teladoc Health by 101.4% during the fourth quarter. Van ECK Associates Corp now owns 9,150 shares of the health services provider’s stock valued at $64,000 after purchasing an additional 4,607 shares during the last quarter. Johnson Financial Group Inc. grew its holdings in shares of Teladoc Health by 41,045.8% during the third quarter. Johnson Financial Group Inc. now owns 9,875 shares of the health services provider’s stock valued at $76,000 after purchasing an additional 9,851 shares during the last quarter. Finally, Cibc World Markets Corp acquired a new stake in shares of Teladoc Health during the 4th quarter worth approximately $82,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on TDOC shares. Barclays cut their target price on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 26th. Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd. Canaccord Genuity Group boosted their price objective on Teladoc Health from $10.00 to $11.00 and gave the company a “buy” rating in a report on Tuesday. Bank of America upped their price objective on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Finally, Citigroup upped their price objective on Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a research note on Tuesday, May 5th. Five research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $7.73.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.